Article
EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma.
Journal of clinical pathology - 1 Sept 2013
Cooper W A, Yu B, Yip P Y, Ng C C, Lum T, Farzin M, Trent R J, Mercorella B, Clarkson A, Kohonen-Corish M R J, Horvath L G, Kench J G, McCaughan B, Gill A J, O'Toole S A
Abstract excerpt
AIM: We assessed the diagnostic accuracy of epidermal growth factor receptor (EGFR) mutant-specific antibodies for detecting two common activating EGFR mutations. METHODS: Immunohistochemical expression of mutation-specific antibodies against EGFR exon 19 deletion E746-A750 ((c.2235_2249del15 or c.2236_2250del15, p. Glu746_Ala750del) and exon 21 L858R point mutation (c.2573T>G, p.Leu858Arg) were assessed in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
